Renal and liver injury following the treatment of COVID-19 by remdesivir

Mohsen Mohammad Rahimi ¹ , Elham Jahantabi ², Behzad Lotfi ³, Mehdi Forouzesh ⁴, Rohollah Valizadeh ⁵ , Saman Farshid ⁶ *

Cited by CrossRef: 16

1- Ahmad R, Al-Sammak M. HISTOLOGICAL ASSESSMENT OF REMDESIVIR ON KIDNEY AND LIVER OF ALBINO RATS IN DIFFERENT DOSES AND THEIR WITHDRAWAL. MMSL. 2024;93(1):10 [Crossref]

2- Sadeghi S, Kalantari Y, Shokri S, Fallahpour M, Nafissi N, Goodarzi A, Valizadeh R. Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2 – 21 years old: A Systematic Review and Meta-analysis. Journal of Clinical Virology. 2022;153:105196 [Crossref]

3- Li W, Hua Y, Zhou P, Zhou L, Xu X, Yang J. Characterizing Public Sentiments and Drug Interactions in the COVID-19 Pandemic Using Social Media: Natural Language Processing and Network Analysis. J Med Internet Res. 2025;27:e63755 [Crossref]

4- Sadeghmoghadam L, Daneshfar M, Sharifi F, Alizad V. How the first cases of COVID-19 in 10 countries become infected? A case series. Respiratory Medicine Case Reports. 2023;46:101219 [Crossref]

5- Luo Q, Zheng Y, Zhang J. Combination Therapies against COVID-19. Front Biosci (Landmark Ed). 2022;27(9) [Crossref]

6- Kouchek M, Miri M, Aghakhani K, Memarian A. ABO blood group is related to the prevalence, severity, and mortality rate of COVID-19. Medicina Clínica Práctica. 2024;7(3):100442 [Crossref]

7- Michalak A, Lach T, Szczygieł K, Cichoż-Lach H. COVID-19, Possible Hepatic Pathways and Alcohol Abuse—What Do We Know up to 2023?. IJMS. 2024;25(4):2212 [Crossref]

8- Hajebi A, Rasoulian M, Fathi M, Tiyuri A, Abbasinejad M, Naserbakht M, Asadi A, Khademoreza N. Randomized controlled trial for the efficacy of three versus five sessions of grief counseling on the psychological aspects following COVID-19 bereavement: A study protocol. Front Psychiatry. 2022;13 [Crossref]

9- Gharebaghi N, Farshid S, Boroofeh B, Nejadrahim R, Mousavi J, Dindarian S, Mohammadi S. Evaluation of epidemiology, clinical features, prognosis, diagnosis and treatment outcomes of patients with COVID‐19 in West Azerbaijan Province. Int J Clinical Practice. 2021;75(6) [Crossref]

10- Nematshahi M, Soroosh D, Neamatshahi M, Attarian F, Rahimi F. Factors predicting readmission in patients with COVID-19. BMC Res Notes. 2021;14(1) [Crossref]

11- Tavakoli N, Nafissi N, Shokri S, Fallahpour M, Soleimani S, Riahi T, Kalantari S, Javan A, Goodarzi A, Valizadeh R. Pediatric and adolescent COVID‐19 vaccination side effects: A retrospective cohort study of the Iranian teenage group in 2021. Journal of Medical Virology. 2022;94(10):4890 [Crossref]

12- Ebrahimi H, Atashzadeh Shoorideh F, Reza Sohrabi M, Ebrahimi M, Hosseini M. An Analysis of Approaches to Reduction of HIV Stigma across the World through educational interventions: A Scoping Review. Invest Educ Enferm. 2024;42(1) [Crossref]

13- Ali S, Khalid S, Afridi M, Akhtar S, Khader Y, Akhtar H. Notes from the Field: The Combined Effects of Tocilizumab and Remdesivir in a Patient with Severe COVID-19 and Cytokine Release Syndrome. JMIR Public Health Surveill. 2021;7(5):e27609 [Crossref]

14- Ghelichi-Ghojogh M, Khezri R, Rezaei F, Aljalili S, Valizadeh R, Sadighpour T. Health inequality in COVID-19 vaccination coverage. Health Science Monitor. 2023;2(1):10 [Crossref]

15- Roshanshad R, Roshanshad A, Fereidooni R, Hosseini-Bensenjan M. COVID-19 and liver injury: Pathophysiology, risk factors, outcome and management in special populations. World J Hepatol. 2023;15(4):441 [Crossref]